Mu and Improved: Flushing Opioid-Induced Constipation Down the Drain

<p>Danielle M. Hess, PharmD (<a href='https://twitter.com/dhess_09'>@dhess_09</a>) describes the pathophysiology of opioid-induced constipation (OIC), evaluates literature depicting the safety and efficacy of peripherally-acting mu-opioid receptor antagonists (PAMORAs) for the treatment of OIC and applies the clinical pearls of PAMORAs to patient care.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>